Status:

COMPLETED

To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children

Lead Sponsor:

Johnson & Johnson Consumer and Personal Products Worldwide

Conditions:

Atopic Dermatitis

Eligibility:

All Genders

2-12 years

Phase:

NA

Brief Summary

The purpose of this study was to evaluate the safety of the investigational study product and see how well it works to relieve signs and symptoms of children with mild to moderate Atopic Dermatitis (A...

Detailed Description

This was a multi-center, double-blind, randomized, active-controlled trial in children 2 to 12 years of age with mild to moderate AD. A sufficient number of subjects were screened to ensure that appro...

Eligibility Criteria

Inclusion

  • Post-menarchal female subjects must have a negative urine pregnancy test
  • Willing to provide written informed consent/assent
  • Diagnosed as having mild to moderate Atopic Dermatitis (AD)
  • Willing to stop all moisturizers and/or other skin barrier cream or emulsion treatments for the AD condition during the test period and replace with the investigational product assigned in this trial
  • Willing to replace their body wash and/or soaps with the one provided in this trial

Exclusion

  • Severe AD as determined by the Rajka-Langeland Severity Index
  • AD requiring systemic, super-potent (Class I) or potent (Class II or III) topical corticosteroids. If the subject requires any of these medications as rescue therapy during the study, the subject will be discontinued from the trial
  • History of allergy or hypersensitivity to the ingredients of the test devices, nuts or nut oil
  • Cutaneous or systemic viral (including HIV or AIDS), mycotic or bacterial disease requiring a topical or systemic therapy
  • Diabetes mellitus that cannot be controlled by diet alone (i.e., requires systemic medications for control)

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT00886587

Start Date

April 1 2009

End Date

June 1 2009

Last Update

May 23 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Thomas J. Stephens & Associates, Inc

Colorado Springs, Colorado, United States, 80915

2

Academic Dermatology Associates

Albuquerque, New Mexico, United States, 87106